A QUALITATIVE INTERVIEW STUDY TO EXPLORE THE USE OF ADVERSE EVENT MITIGATION STRATEGIES AMONG ADULTS RECEIVING AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) IN REAL WORLD SETTINGS

Authors

Juzar Ali, LSU Health Sciences Center - New OrleansFollow
J. Wu, Insmed Inc., Bridgewater, NJ
M. Hassan, Insmed Inc., Bridgewater, NJ
J. Tsai, OPEN Health, Bethesda, MD
N. Touba, OPEN Health, Bethesda, MD
K. McCarrier, OPEN Health, Bethesda, MD
M. Ballard, Insmed Inc., Bridgewater, NJ
A. Chatterjee, Insmed Inc., Bridgewater, NJ

Document Type

Conference Proceeding

Publication Date

11-6-2023

Publication Title

Thorax

Abstract

British Thoracic Society Winter Meeting 2023, November 22 - 24, 2023, London, UK

First Page

A162

Last Page

A163

Volume

78

Comments

Abstract Number: P93

Recommended Citation

Ali, Juzar; Wu, J.; Hassan, M.; Tsai, J.; Touba, N.; McCarrier, K.; Ballard, M.; and Chatterjee, A., "A QUALITATIVE INTERVIEW STUDY TO EXPLORE THE USE OF ADVERSE EVENT MITIGATION STRATEGIES AMONG ADULTS RECEIVING AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) IN REAL WORLD SETTINGS" (2023). School of Medicine Faculty Publications. 2640.
https://digitalscholar.lsuhsc.edu/som_facpubs/2640
10.1136/thorax-2023-BTSabstracts.245